• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corp (NQ: MASI )

142.89 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Masimo Corp

< Previous 1 2 3 4 5 6 7 Next >
Apple's Week Of Peaks And Valleys: From Record iPhone Sales To Legal And Regulatory Challenges
October 27, 2024
Apple's rollercoaster week: facing U.S. probe, patent dispute, streaming services leaving App Store, but sets new iPhone sales record. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Apple Secures Victory In Masimo Patent Dispute With Token Damages Of $250
October 27, 2024
A Delaware jury has ruled in favor of Apple in a patent infringement case against Masimo, awarding Cupertino a symbolic $250 in damages. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
October 25, 2024
Via Benzinga
How Is The Market Feeling About Masimo?
October 22, 2024
Via Benzinga
$1000 Invested In Masimo 10 Years Ago Would Be Worth This Much Today
October 21, 2024
Via Benzinga
Top 2 Health Care Stocks That Are Ticking Portfolio Bombs
October 10, 2024
Via Benzinga
A Look Into Masimo Inc's Price Over Earnings
October 01, 2024
Via Benzinga
Assessing Masimo: Insights From 6 Financial Analysts
June 03, 2024
Via Benzinga
Forecasting The Future: 6 Analyst Projections For Masimo
April 15, 2024
Via Benzinga
Masimo Stock Gets Relative Strength Rating Upgrade
October 01, 2024
The Relative Strength Rating for Masimo stock jumped into a higher percentile Tuesday, as it got a lift from 69 to 78. 
Via Investor's Business Daily
Why Masimo Stock Crushed the Market Today
September 25, 2024
The company seems to be effecting a smooth transition in its leadership. 
Via The Motley Fool
Masimo CEO Joe Kiani Resigns Following Politan Proxy Battle; Shares Jump
September 25, 2024
The company is facing numerous changes following a proxy battle with activist investor Politan. 
Via Investor's Business Daily
Masimo Names Interim CEO As Activist Board Members Step In; Joe Kiani Exits Amid Legal Clash
September 25, 2024
Masimo stock is up as the company announces leadership changes, reiterates strong financial guidance, and expects Q3 revenue of $495M-$515M. 
Via Benzinga
MASI Stock Earnings: Masimo Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
MASI stock results show that Masimo beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
3 Healthcare Stocks to Buy Now: Q3 Edition
July 21, 2024
U.S. healthcare expenditures will grow by 5.6% annually, presenting a revenue tailwind for these healthcare stocks to buy now. 
Via InvestorPlace
Analyst Scoreboard: 5 Ratings For Masimo
March 25, 2024
Via Benzinga
What's Going On With Health Technology Company Masimo Shares Today?
July 09, 2024
Masimo reportedly considers an $850 million to $950 million bid for its consumer business amid active joint venture discussions while reporting strong Q2 healthcare revenue growth and record customer... 
Via Benzinga
Why Smartsheet Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
June 06, 2024
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 06, 2024
Via Benzinga
Five Below Posts Weak Q1 Results, Joins Sprinklr, Dorian LPG And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
June 06, 2024
Via Benzinga
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 08, 2024
Via Benzinga
MASI Stock Earnings: Masimo Misses EPS, Beats Revenue for Q1 2024
May 07, 2024
MASI stock results show that Masimo missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024
April 25, 2024
The medical device market is growing fast, and top medical device firms can become takeover targets. Here are three medtech stocks to watch. 
Via InvestorPlace
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
April 15, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
How's AT&T Handling Things?
April 09, 2024
We've also got a look at 3M's spinoff, gold prices, and the beef industry. 
Via The Motley Fool
Can a New CEO Fix Boeing?
April 06, 2024
We also talk with e.l.f. Beauty CEO Tarang Amin about how the company is succeeding. 
Via The Motley Fool
Boeing's Leadership Shake-Up
April 06, 2024
And IWG CEO Mark Dixon talks with us about the global shift toward hybrid work. 
Via The Motley Fool
Tim Cook-Led Tech Giant Appeals To US Court For Overturning Import Ban On Its Apple Watches
April 06, 2024
Apple is appealing to reverse a U.S. import ban on certain Apple Watches stemming from a patent dispute with Masimo Corporation, arguing the patented Masimo wearable was theoretical and challenging the... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. 
Via Benzinga
Masimo Breaks Out To Eight-Month High On Proposed Consumer Biz Separation
March 25, 2024
The company is considering a separation for its audio and consumer-facing businesses. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap